APRE
Aprea Therapeutics, Inc.
+0.01 (+1.29%)0.74USD70.1K成交股數9.3M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.5M | 1.6M | 1.0M | 1.6M | 1.9M | 2.5M | 2.8M | 2.6M | 1.6M | 2.0M | 2.1M | 2.2M |
| 銷售管理費用 | 1.6M | 1.8M | 1.6M | 1.5M | 1.6M | 1.8M | 1.6M | 1.9M | 1.9M | 1.6M | 1.7M | 1.7M |
| 營業利益 | −4.0M+19% | −3.4M-16% | −2.6M-35% | −3.1M-19% | −3.4M+8% | −4.1M+11% | −4.1M+16% | −3.8M+5% | −3.1M | −3.7M | −3.5M | −3.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −3.6M+11% | −3.3M-16% | −2.5M-35% | −3.0M-14% | −3.2M+15% | −3.9M+14% | −3.8M+18% | −3.5M+6% | −2.8M | −3.4M | −3.2M | −3.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.07-87% | -0.22-67% | -0.27-58% | -0.47-19% | -0.53-21% | -0.66-25% | -0.64-26% | -0.58-33% | -0.67 | -0.88 | -0.86 | -0.87 |
| 稀釋股數 | 53.5M | 14.7M | 6.5M | 6.4M | 6.1M | 6.0M | 5.9M | 5.9M | 4.2M | 3.6M | 3.7M | 3.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 41.2M | 46.5M | 14.6M | 13.7M | 16.5M | 19.3M | 26.2M | 28.7M | 32.4M | 21.6M | 25.4M | 27.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 42.3M | 47.6M | 15.9M | 14.3M | 17.3M | 20.2M | 26.9M | 30.0M | 33.2M | 22.7M | 25.8M | 28.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | 4.0M |
| 股東權益 | 38.5M | 41.6M | 12.4M | 10.9M | 13.4M | 15.5M | 21.9M | 25.6M | 28.9M | 17.0M | 20.3M | 23.4M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | 13.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.8M-24% | – | – | – | −3.6M | – | – | −3.9M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 8K | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −3.9M | – | – | – |
| 折舊攤銷 | – | 5K | – | – | – | 5K | – | – | 6K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −12.6M | –% | -1.93 | – |
| FY2024 | – | – | −13.0M | –% | -2.35 | −13.6M |
| FY2023 | – | – | −14.3M | –% | -3.95 | −12.3M |
| FY2022 | – | – | −113M | –% | -67.99 | – |
| FY2021 | – | – | −37.1M | –% | -34.88 | – |
| FY2020 | – | – | −53.5M | –% | -50.61 | −41.8M |
| FY2019 | – | – | −28.1M | –% | -4.67 | −26.7M |
| FY2018 | – | – | −15.5M | –% | -13.45 | −15.3M |